Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients

被引:1
作者
Yilmaz, Nusret [1 ]
Sari, Ramazan [1 ]
Suleymanlar, Gultekin [2 ]
Ozdem, Sebahat [3 ]
机构
[1] Akdeniz Univ, Sch Med, Div Endocrinol, Antalya, Turkey
[2] Akdeniz Univ, Sch Med, Div Nephrol, Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Biochem, Antalya, Turkey
关键词
Incretin; Glucagon-like peptide-1; Glucose dependent insulinotropic polypeptide; Post-transplant diabetes; Renal transplantation; GLUCAGON-LIKE PEPTIDE-1; INSULIN SENSITIVITY; SECRETION; GLUCOSE; RELEASE;
D O I
10.1016/j.jnma.2020.03.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Immunosuppressive drugs used in transplantation patients, may contribute to the development of post-transplant diabetes mellitus through their possible adverse effects on incretins. We aimed to compare the effects of different immunosuppressive drugs used in renal transplantation patients on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels. Patients and methods: Forty five subjects were enrolled in the study (cyclosporine-treated 15 and tacrolimus-treated renal transplant patients 15, and healthy volunteers as a control group 15). Oral glucose tolerance test with 75 gr glucose was performed. GLP-1 and GIP levels were measured at 0 (baseline), 30, 60, 90, 120 min using ELISA method. Results: A statistically significant levet of difference was detected in GLP-1 levels at the baseline, 30th and 120th minutes among all three groups (p < 0,001, p = 0,026 and p = 0,022, respectively). Baseline GLP-1 levels in cyclosporine-treated renal transplant patients were higher than in both tacrolimus-treated renal transplant patients {p = 0,016) and control groups (p < 0,001). GLP-1 levels at the 30th minute were higher in tacrolimus-treated renal transplant patients when compared to the cyclosporine-treated renal transplant patients (p = 0,024). GLP-1 levels at the 120th minute were higher in tacrolimus-treated renal transplant patients than the control group (p = 0,024). The areas under the curve of GLP-1 was higher in tacrolimus-treated renal transplant patients when compared to the control group (p = 0,018). GIP levels at 120th was lower in cyciosporine-treated renal transplant patients when compared to control group (p = 0,003). Conclusion: These findings showed a temporally affected incretin hormones in renal transplant patients, a preserved GLP-1 response to an oral glucose load in renal transplant patients on cyclosporine and increased GLP-1 response to an oral glucose load in those on tacrolimus.
引用
收藏
页码:250 / 257
页数:8
相关论文
共 23 条
  • [1] [Anonymous], 1997, AM J PHYSL ENDOCRINO, DOI DOI 10.1152/AJPENDO
  • [2] Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
    Bagger, Jonatan I.
    Knop, Filip K.
    Lund, Asger
    Vestergaard, Henrik
    Holst, Jens J.
    Vilsboll, Tina
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) : 737 - 745
  • [3] The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells
    Bussiere, C. T.
    Lakey, J. R. T.
    Shapiro, A. M. J.
    Korbutt, G. S.
    [J]. DIABETOLOGIA, 2006, 49 (10) : 2341 - 2349
  • [4] New-onset diabetes after transplantation: 2003 International Consensus Guidelines
    Davidson, J
    Wilkinson, A
    Dantal, J
    Dotta, F
    Haller, H
    Hernández, D
    Kasiske, BL
    Kiberd, B
    Krentz, A
    Legendre, C
    Marchetti, P
    Markell, M
    van der Woude, FJ
    Wheeler, DC
    [J]. TRANSPLANTATION, 2003, 75 (10) : SS3 - SS24
  • [5] The biology of incretin hormones
    Drucker, DJ
    [J]. CELL METABOLISM, 2006, 3 (03) : 153 - 165
  • [6] Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
    Gautier, J. -F.
    Choukem, S. -P.
    Girard, J.
    [J]. DIABETES & METABOLISM, 2008, 34 : S65 - S72
  • [7] Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients
    Henchoz, E
    D'Alessio, DA
    Gillet, M
    Halkic, N
    Matzinger, O
    Goy, JJ
    Chioléro, R
    Tappy, L
    Schneiter, P
    [J]. TRANSPLANTATION, 2003, 76 (06) : 923 - 929
  • [8] Different Effects of FK506, Rapamycin, and Mycophenolate Mofetil on Glucose-Stimulated Insulin Release and Apoptosis in Human Islets
    Johnson, James D.
    Ao, Ziliang
    Ao, Peter
    Li, Hong
    Dai, Long-Jun
    He, Zehua
    Tee, May
    Potter, Kathryn J.
    Klimek, Agnieszka M.
    Meloche, R. Mark
    Thompson, David M.
    Verchere, C. Bruce
    Warnockt, Garth L.
    [J]. CELL TRANSPLANTATION, 2009, 18 (08) : 833 - 845
  • [9] Reduced incretin effect in type 2 diabetes - Cause or consequence of the diabetic state?
    Knop, Filip K.
    Vilsboll, Tina
    Hojberg, Patricia V.
    Larsen, Steen
    Madsbad, Sten
    Volund, Aage
    Holst, Jens J.
    Krarup, Thure
    [J]. DIABETES, 2007, 56 (08) : 1951 - 1959
  • [10] Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects
    Meier, JJ
    Nauck, MA
    Kranz, D
    Holst, JJ
    Deacon, CF
    Gaeckler, D
    Schmidt, WE
    Gallwitz, B
    [J]. DIABETES, 2004, 53 (03) : 654 - 662